Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and its Rifampicin resistance at Felege Hiwot and Debre Tabor Hospitals; Northwest Ethiopia: A preliminary implementation research
Author(s) : ABAY TESHAGER, AWOKE DERBIE, AYENEW BIRHAN, BEGNA TULU, DANIEL MEKONNEN, DERESE HAILU, ENDALEW YIZENGAW, FANTAHUN BIADGLEGNE, FETLEWORK BEREDED, SEBLE WORKU, WORKINEH AYALEW, YESUF ADEM, YINEBEB MEZGEBU, YOHANNES ZENEBE
Abstract
The World Health Organization in 2010 indorsed Xpert MTB/RIF (Xpert) assay for the diagnosis of tuberculosis and multidrug resistant tuberculosis. However the use of this novel diagnostic method is still limited in a high TB and human immunodeficiency virus burden settings including Ethiopia.Therefore we conducted this study to describe the first implementation result of Xpert assay in the diagnosis of TB TB/HIV and MDR-TB at Felege Hiwot Referral Hospital (FHRH) and Debre Tabor General Hospital (DTGH) Northwest Ethiopia.
Full Paper PDF
